Skip to main content

Table 3 Association of CAD with serum NEFA in HUA men

From: Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia

NEFA

n

Conc range,

OR(95%CI)

quartile

 

mmol/L

Crude

Model 1

Model 2

Quartile 1

80

 ≤ 0.27

Reference

Reference

Reference

(low)

Quartile 2

88

0.28–0.37

0.967

0.988

1.188

   

(0.521, 1.794)

(0.524, 1.861)

(0.553, 2.554)

Quartile 3

89

0.38–0.49

1.259

1.319

2.016

   

(0.685, 2.314)

(0.706, 2.466)

(0.936, 4.342)

Quartile 4

93

 ≥ 0.50

8.667

10.148

11.244

(high)

  

(4.270, 17.590)

(4.879, 21.105)

(4.740, 26.669)

β

  

0.621

0.667

0.747

SE

  

0.106

0.110

0.135

P for trend

  

 < 0.001

 < 0.001

 < 0.001

  1. Serum NEFA was divided into quartiles (quartile 1: < 25th, quartile 2: 25–50th, quartile 3: 50–75th, quartile 4: > 75th percentile)
  2. Crude: No adjustment
  3. Model 1: Adjusted for age, smoking, alcohol consumption, Diabetes Mellitus, Hypertension, SBP, DBP
  4. Model 2: Adjusted for the same variables as Model 1 as well as Urea, Cr,UA, FPG, TC, TG, HDL-c and LDL-c
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X